RNAZ ▼ -7.3% - TransCode Therapeutics, Inc. $RNAZ RNAZ - TransCode Therapeutics Announces Leadership Transition TransCode Therapeutics announced a leadership transition, which sent shares of the biopharmaceutical company down 7.3% today. Leadership changes at small-cap biotech firms often prompt investor caution, particularly when details about succession planning or strategic direction remain unclear. 10-SEP-2026 04:10 PM ET